// App-Quantinova.ai

e13054 : Compliance and impact of screening on individuals at high risk of breast and ovarian cancer syndrome (BOCS).

Researchers

Presenter

  • Carmen Guillen

Principal Investigators

  • Maria-Teresa Salazar-Lopez

  • Maria-Dolores Rubio

  • Miguel Chiva

  • Silvia Perez-Rodrigo

  • Jesus Solera

  • Pilar Martinez

  • Vanessa Pachon Olmos

  • Reyes Ferreiro Monteagudo

  • Julie Earl

  • Silvia Patricia Cortez Castedo

  • Maria Villamayor-Delgado

  • Samuel Hernandez Sarmiento

  • Maria-Isabel Humanes

Medical Centers

  • Medical Oncology Department, Ramon y Cajal University Hospital, IRYCIS, RETICC of Spanish Ministry of Science and Innovation, Madrid, Spain

  • Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain

  • Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain

  • Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain

  • Instituto Genetica Molecular, Hospital La Paz, Madrid, Spain

  • Laboratorio de Genetica Molecular. La Paz University Hospital, Madrid, Spain

  • Ramon y Cajal University Hospital, Madrid, Spain

  • Hospital Ramon y Cajal, Madrid, Spain

  • Hospital Universitario Doctor Negrin, Las Palmas De Gran Canaria, Spain

  • RAMON Y CAJAL UNIVERSITY HOSPITAL, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast and ovarian cancer syndrome

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved